[{"data":1,"prerenderedAt":598},["ShallowReactive",2],{"university-accademia-di-belle-arti-di-frosinone":3,"university-review-stats-accademia-di-belle-arti-di-frosinone-cmn0jqkf80x9hh91ca8qgfwl3":37,"university-similar-accademia-di-belle-arti-di-frosinone":40,"university-topics-accademia-di-belle-arti-di-frosinone":138},{"id":4,"slug":5,"name":6,"shortName":6,"type":7,"foundedYear":8,"description":8,"shortDescription":9,"isVerified":10,"city":11,"region":12,"countryCode":13,"countryName":14,"latitude":15,"longitude":16,"campusCount":17,"qsWorldRank":8,"theWorldRank":8,"arwuWorldRank":8,"nationalRank":8,"rankingYear":18,"tuitionMin":19,"tuitionMax":19,"tuitionCurrency":20,"tuitionPerYear":21,"tuitionIncFees":10,"totalStudents":8,"undergraduateStudents":8,"postgraduateStudents":8,"doctoralStudents":8,"internationalPercent":8,"acceptanceRate":8,"testingPolicy":8,"admissionPlans":22,"graduationRate":8,"studentFacultyRatio":8,"researchOutputScore":23,"citationsPerFaculty":24,"academicCalendar":25,"scorecardId":8,"avgNetPrice":8,"pellGrantRate":8,"fafsaCompletionRate":8,"medianDebtAtGraduation":8,"medianEarnings10yr":8,"satMathMidpoint":8,"actMidpoint":8,"carnegieClassification":8,"openAlexId":26,"worksCount":27,"citedByCount":28,"hIndex":23,"i10Index":29,"twoYearMeanCitedness":24,"worksCountLastYear":30,"citedByCountLastYear":31,"openAlexUpdatedAt":32,"websiteUrl":33,"admissionsUrl":8,"email":8,"phone":8,"socialLinks":8,"logoUrl":8,"heroImageUrl":8,"galleryImages":34,"videoTourUrl":8,"createdAt":35,"updatedAt":36},"cmn0jqkf80x9hh91ca8qgfwl3","accademia-di-belle-arti-di-frosinone","Accademia di Belle Arti di Frosinone","university",null,"Accademia di Belle Arti di Frosinone is a public institution of higher education in Frosinone, Italy, specializing in the visual arts. The academy has produced 520 works with an h-index of 49, reflecting its research and creative output in the arts sector. It is not currently ranked in the QS World University Rankings.",false,"Frosinone","Lazio","IT","Italy",41.63520050048828,13.35392475128174,1,2024,0,"USD",true,[],49,0.8186274509803921,"semester","https:\u002F\u002Fopenalex.org\u002FI3130785504",520,9180,208,81,80,"2026-06-06T02:35:34.605297Z","http:\u002F\u002Fwww.accademiabellearti.fr.it\u002F",[],"2026-03-21T20:32:36Z","2026-06-06T02:36:43.728908Z",{"universityId":4,"totalReviews":19,"verifiedReviews":19,"averageOverallRating":19,"averageAcademicsRating":8,"averageCampusLifeRating":8,"averageCareerServicesRating":8,"averageSocialRating":8,"averageValueRating":8,"averageSafetyRating":8,"averageDiversityRating":8,"averageSentiment":19,"sentimentLabel":38,"ratingDistributionJson":8,"topKeyPhrasesJson":8,"lastCalculatedAt":39},"neutral","0001-01-01T00:00:00",[41,51,61,71,80,91,101,110,120,130],{"id":42,"slug":43,"name":44,"shortName":44,"type":7,"city":45,"countryCode":13,"countryName":14,"qsWorldRank":8,"tuitionMin":19,"tuitionMax":19,"tuitionCurrency":20,"region":46,"foundedYear":8,"shortDescription":47,"internationalStudentsPercent":8,"totalStudents":8,"acceptanceRate":8,"testingPolicy":8,"admissionPlans":48,"logoUrl":8,"isVerified":10,"isActive":21,"status":19,"worksCount":49,"hIndex":50},"cmn0js8cq27wrh91c3yagq2w0","abiogen-pharma-italy","Abiogen Pharma (Italy)","Pisa","Toscana","Abiogen Pharma is a private institution based in Pisa, Italy, primarily focused on pharmaceutical research and development rather than traditional academic education. The institution has produced 108 scholarly works and holds an h-index of 38, reflecting its research output in the pharmaceutical sciences. Abiogen Pharma is not ranked in the QS World University Rankings.",[],108,38,{"id":52,"slug":53,"name":54,"shortName":54,"type":7,"city":55,"countryCode":13,"countryName":14,"qsWorldRank":8,"tuitionMin":19,"tuitionMax":19,"tuitionCurrency":20,"region":56,"foundedYear":8,"shortDescription":57,"internationalStudentsPercent":8,"totalStudents":8,"acceptanceRate":8,"testingPolicy":8,"admissionPlans":58,"logoUrl":8,"isVerified":10,"isActive":21,"status":19,"worksCount":59,"hIndex":60},"cmn0jrrr41tyjh91c6eozl2fh","academy-of-fine-arts-of-bari","Academy of Fine Arts of Bari","Bari","Puglia","The Academy of Fine Arts of Bari is a public higher education institution in Bari, Italy, specializing in fine arts and related disciplines. The academy has produced 28 academic works with an h-index of 4, reflecting its research output. It is not currently ranked in the QS World University Rankings.",[],28,4,{"id":62,"slug":63,"name":64,"shortName":64,"type":7,"city":65,"countryCode":13,"countryName":14,"qsWorldRank":8,"tuitionMin":19,"tuitionMax":19,"tuitionCurrency":20,"region":66,"foundedYear":8,"shortDescription":67,"internationalStudentsPercent":8,"totalStudents":8,"acceptanceRate":8,"testingPolicy":8,"admissionPlans":68,"logoUrl":8,"isVerified":10,"isActive":21,"status":19,"worksCount":69,"hIndex":70},"cmn0jsf3r2dkrh91cabc6j1zu","accademia-albertina-delle-belle-arti","Accademia Albertina delle Belle Arti","Turin","Piedmont","Accademia Albertina delle Belle Arti is a public academy of fine arts located in Turin, Italy, specializing in visual arts education and research. The institution has produced 3,097 works with an h-index of 112, reflecting its academic contributions, though it is not ranked in the QS World University Rankings.",[],3097,112,{"id":72,"slug":73,"name":74,"shortName":74,"type":7,"city":75,"countryCode":13,"countryName":14,"qsWorldRank":8,"tuitionMin":19,"tuitionMax":19,"tuitionCurrency":20,"region":76,"foundedYear":8,"shortDescription":77,"internationalStudentsPercent":8,"totalStudents":8,"acceptanceRate":8,"testingPolicy":8,"admissionPlans":78,"logoUrl":8,"isVerified":10,"isActive":21,"status":19,"worksCount":79,"hIndex":17},"cmn0jp9sr02hjh91cbjp7ed8s","accademia-di-belle-arti-dellaquila","Accademia di Belle Arti dell'Aquila","L’Aquila","Abruzzo","Accademia di Belle Arti dell'Aquila is a public academy of fine arts located in L’Aquila, Italy, specializing in visual arts education and training. The institution has a modest research output, with 12 works and an h-index of 1, and is not ranked in the QS World University Rankings.",[],12,{"id":81,"slug":82,"name":83,"shortName":83,"type":7,"city":84,"countryCode":13,"countryName":14,"qsWorldRank":8,"tuitionMin":19,"tuitionMax":19,"tuitionCurrency":20,"region":85,"foundedYear":8,"shortDescription":86,"internationalStudentsPercent":8,"totalStudents":8,"acceptanceRate":8,"testingPolicy":8,"admissionPlans":87,"logoUrl":88,"isVerified":10,"isActive":21,"status":19,"worksCount":89,"hIndex":90},"cmn0jqzyg18u7h91c2ej8jr6h","accademia-di-belle-arti-di-bologna","Accademia di Belle Arti di Bologna","Bologna","Lombardia","Accademia di Belle Arti di Bologna is a public institution of higher education in Bologna, Italy, specializing in fine arts and related disciplines. The academy is recognized for its academic contributions, with 138 works and an h-index of 15, though it is not ranked in the QS World University Rankings.",[],"https:\u002F\u002Fcommons.wikimedia.org\u002Fw\u002Findex.php?title=Special:Redirect\u002Ffile\u002FSatyr%20and%20Woman%20LACMA%2054.12.5.jpg&width=300",138,15,{"id":92,"slug":93,"name":94,"shortName":95,"type":7,"city":96,"countryCode":13,"countryName":14,"qsWorldRank":8,"tuitionMin":19,"tuitionMax":19,"tuitionCurrency":20,"region":46,"foundedYear":8,"shortDescription":97,"internationalStudentsPercent":8,"totalStudents":8,"acceptanceRate":8,"testingPolicy":8,"admissionPlans":98,"logoUrl":8,"isVerified":10,"isActive":21,"status":19,"worksCount":99,"hIndex":100},"cmn0jsn4y2k2lh91cqgb8rkco","accademia-di-belle-arti-di-carrara","Accademia di Belle Arti di Carrara","ABAC","Carrara","Accademia di Belle Arti di Carrara is a public academy of fine arts located in Carrara, Italy, specializing in visual arts education and research. The institution has produced 445 academic works with an h-index of 64, reflecting its scholarly output in the arts. It is not currently ranked in the QS World University Rankings.",[],445,64,{"id":102,"slug":103,"name":104,"shortName":104,"type":7,"city":105,"countryCode":13,"countryName":14,"qsWorldRank":8,"tuitionMin":19,"tuitionMax":19,"tuitionCurrency":20,"region":106,"foundedYear":8,"shortDescription":107,"internationalStudentsPercent":8,"totalStudents":8,"acceptanceRate":8,"testingPolicy":8,"admissionPlans":108,"logoUrl":8,"isVerified":10,"isActive":21,"status":19,"worksCount":50,"hIndex":109},"cmn0jpe6s05boh91cwp0bnz1u","accademia-di-belle-arti-di-catania","Accademia di Belle Arti di Catania","Catania","Sicilia","Accademia di Belle Arti di Catania is a public institution of higher education in Catania, Italy, specializing in fine arts and visual arts disciplines. The academy has produced 38 academic works with an h-index of 7, reflecting its research output in the arts field. It is not currently ranked in the QS World University Rankings.",[],7,{"id":111,"slug":112,"name":113,"shortName":114,"type":7,"city":115,"countryCode":13,"countryName":14,"qsWorldRank":8,"tuitionMin":19,"tuitionMax":19,"tuitionCurrency":20,"region":116,"foundedYear":8,"shortDescription":117,"internationalStudentsPercent":8,"totalStudents":8,"acceptanceRate":8,"testingPolicy":8,"admissionPlans":118,"logoUrl":8,"isVerified":10,"isActive":21,"status":19,"worksCount":119,"hIndex":100},"cmn0jpn4u0bmkh91cq74d310n","accademia-di-belle-arti-di-catanzaro","Accademia di Belle Arti di Catanzaro","AAC","Catanzaro","Calabria","Accademia di Belle Arti di Catanzaro is a public institution of higher education located in Catanzaro, Italy, specializing in the fine arts. The academy has produced 558 works with an h-index of 64, reflecting its research and creative output. It is not currently ranked in the QS World University Rankings.",[],558,{"id":121,"slug":122,"name":123,"shortName":123,"type":7,"city":124,"countryCode":13,"countryName":14,"qsWorldRank":8,"tuitionMin":19,"tuitionMax":19,"tuitionCurrency":20,"region":46,"foundedYear":8,"shortDescription":125,"internationalStudentsPercent":8,"totalStudents":8,"acceptanceRate":8,"testingPolicy":8,"admissionPlans":126,"logoUrl":127,"isVerified":10,"isActive":21,"status":19,"worksCount":128,"hIndex":129},"cmn0jsjom2h77h91c0va9xv6x","accademia-di-belle-arti-di-firenze","Accademia di Belle Arti di Firenze","Florence","Accademia di Belle Arti di Firenze is a public fine arts academy located in Florence, Italy, specializing in visual arts education and research. The institution has produced 126 scholarly works with an h-index of 14, reflecting its academic output in the arts. It is not currently ranked in the QS World University Rankings.",[],"https:\u002F\u002Fcommons.wikimedia.org\u002Fw\u002Findex.php?title=Special:Redirect\u002Ffile\u002FAccademia%20di%20Belle%20Arti.JPG&width=300",126,14,{"id":131,"slug":132,"name":133,"shortName":133,"type":7,"city":134,"countryCode":13,"countryName":14,"qsWorldRank":8,"tuitionMin":19,"tuitionMax":19,"tuitionCurrency":20,"region":56,"foundedYear":8,"shortDescription":135,"internationalStudentsPercent":8,"totalStudents":8,"acceptanceRate":8,"testingPolicy":8,"admissionPlans":136,"logoUrl":8,"isVerified":10,"isActive":21,"status":19,"worksCount":79,"hIndex":137},"cmn0jqw0015u9h91cw0k64bn8","accademia-di-belle-arti-di-foggia","Accademia di Belle Arti di Foggia","Foggia","Accademia di Belle Arti di Foggia is a public institution of higher education in Foggia, Italy, specializing in fine arts and related disciplines. The academy has produced 12 academic works with an h-index of 2, reflecting its modest research output. It is not currently ranked in the QS World University Rankings.",[],2,[139,163,181,204,222,241,258,277,293,311,330,352,373,391,406,425,442,458,476,492,510,526,542,560,583],{"id":140,"displayName":141,"keywords":142,"worksCount":153,"score":17,"subfield":154,"field":157,"domain":160},"https:\u002F\u002Fopenalex.org\u002FT11752","Cancer Treatment and Pharmacology",[143,144,145,146,147,148,149,150,151,152],"Chemotherapy-Induced Peripheral Neuropathy","Taxanes","Oxaliplatin","Paclitaxel","Neurotoxicity","Metastatic Breast Cancer","Eribulin Mesylate","Neuroprotective Strategies","Microtubule-Targeting Agents","Quality of Life",52,{"id":155,"displayName":156},"https:\u002F\u002Fopenalex.org\u002Fsubfields\u002F2730","Oncology",{"id":158,"displayName":159},"https:\u002F\u002Fopenalex.org\u002Ffields\u002F27","Medicine",{"id":161,"displayName":162},"https:\u002F\u002Fopenalex.org\u002Fdomains\u002F4","Health Sciences",{"id":164,"displayName":165,"keywords":166,"worksCount":177,"score":17,"subfield":178,"field":179,"domain":180},"https:\u002F\u002Fopenalex.org\u002FT11067","Colorectal Cancer Treatments and Studies",[167,168,169,170,171,172,173,174,175,176],"Cetuximab","KRAS Mutations","Fluorouracil","Metastatic Colorectal Cancer","BRAF Mutation","Bevacizumab","Chemotherapy","EGFR Inhibitors","Molecular Subtypes","Precision Medicine",33,{"id":155,"displayName":156},{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":182,"displayName":183,"keywords":184,"worksCount":194,"score":17,"subfield":195,"field":198,"domain":201},"https:\u002F\u002Fopenalex.org\u002FT10183","Breast Cancer Treatment Studies",[185,186,187,175,188,189,190,191,192,193],"Gene Expression","Breast Tumours","Treatment Response","Prognostic Markers","Neoadjuvant Therapy","Radiotherapy","Hormone Receptors","Survival Analysis","Clinical Practice Guidelines",31,{"id":196,"displayName":197},"https:\u002F\u002Fopenalex.org\u002Fsubfields\u002F1306","Cancer Research",{"id":199,"displayName":200},"https:\u002F\u002Fopenalex.org\u002Ffields\u002F13","Biochemistry, Genetics and Molecular Biology",{"id":202,"displayName":203},"https:\u002F\u002Fopenalex.org\u002Fdomains\u002F1","Life Sciences",{"id":205,"displayName":206,"keywords":207,"worksCount":218,"score":17,"subfield":219,"field":220,"domain":221},"https:\u002F\u002Fopenalex.org\u002FT10755","HER2\u002FEGFR in Cancer Research",[208,209,210,211,212,213,214,215,216,217],"HER2","breast cancer","trastuzumab","EGFR","monoclonal antibody","chemotherapy","metastatic","receptor tyrosine kinases","neuregulin 1","ADAM metalloproteinases",27,{"id":155,"displayName":156},{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":223,"displayName":224,"keywords":225,"worksCount":235,"score":17,"subfield":236,"field":239,"domain":240},"https:\u002F\u002Fopenalex.org\u002FT12829","Advanced Breast Cancer Therapies",[226,227,228,229,230,231,232,148,233,234],"CDK4\u002F6 Inhibitors","Breast Cancer","Palbociclib","Letrozole","Ribociclib","Abemaciclib","Hormone Receptor-Positive","Cell Cycle Control","Therapeutic Resistance",20,{"id":237,"displayName":238},"https:\u002F\u002Fopenalex.org\u002Fsubfields\u002F2740","Pulmonary and Respiratory Medicine",{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":242,"displayName":243,"keywords":244,"worksCount":90,"score":17,"subfield":255,"field":256,"domain":257},"https:\u002F\u002Fopenalex.org\u002FT10158","Cancer Immunotherapy and Biomarkers",[245,246,247,248,249,250,251,252,253,254],"Immune Checkpoint Blockade","PD-1 and PD-L1","Tumor Microenvironment","Tumor Mutational Burden","Immune-related Adverse Events","T-cell Exhaustion","Neoantigens","Biomarkers for Immunotherapy","Combination Therapies","Cancer Immunoediting",{"id":155,"displayName":156},{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":259,"displayName":260,"keywords":261,"worksCount":79,"score":17,"subfield":272,"field":275,"domain":276},"https:\u002F\u002Fopenalex.org\u002FT11157","Chronic Lymphocytic Leukemia Research",[262,263,264,265,266,267,268,269,270,271],"Chronic Lymphocytic Leukemia","Genomic Aberrations","BTK Inhibitors","Rituximab","Ibrutinib","Prognostic Factors","TP53 Mutation","Waldenström Macroglobulinemia","Immunoglobulin Mutation","Therapeutic Targets",{"id":273,"displayName":274},"https:\u002F\u002Fopenalex.org\u002Fsubfields\u002F2716","Genetics",{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":278,"displayName":279,"keywords":280,"worksCount":289,"score":17,"subfield":290,"field":291,"domain":292},"https:\u002F\u002Fopenalex.org\u002FT12103","Cancer Risks and Factors",[281,282,283,227,284,285,286,173,287,288],"Obesity","Cancer","Body Mass Index","Pregnancy","Adiposity","Metabolic Syndrome","Hormones","Survival",11,{"id":155,"displayName":156},{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":294,"displayName":295,"keywords":296,"worksCount":307,"score":17,"subfield":308,"field":309,"domain":310},"https:\u002F\u002Fopenalex.org\u002FT10543","Prostate Cancer Treatment and Research",[297,298,299,300,301,302,303,304,305,306],"Prostate Cancer","Androgen Receptor","Genomic Profiling","Hormone Therapy","Metastatic Prostate Cancer","Immunotherapy","Genetic Mutations","Clinical Trials","Biomarkers","Molecular Biology",10,{"id":237,"displayName":238},{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":312,"displayName":313,"keywords":314,"worksCount":324,"score":17,"subfield":325,"field":328,"domain":329},"https:\u002F\u002Fopenalex.org\u002FT10285","Venous Thromboembolism Diagnosis and Management",[315,316,317,318,319,320,321,322,323,193],"Venous Thromboembolism","Antithrombotic Therapy","Pulmonary Embolism","Deep Vein Thrombosis","Cancer-Associated Thrombosis","Prophylaxis","Risk Factors","Diagnosis","Treatment",9,{"id":326,"displayName":327},"https:\u002F\u002Fopenalex.org\u002Fsubfields\u002F2724","Internal Medicine",{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":331,"displayName":332,"keywords":333,"worksCount":344,"score":17,"subfield":345,"field":348,"domain":351},"https:\u002F\u002Fopenalex.org\u002FT10487","Plant and animal studies",[334,335,336,337,338,339,340,341,342,343],"Pollinator Decline","Ecosystem Services","Plant-Animal Interactions","Biodiversity","Crop Pollination","Habitat Fragmentation","Mutualistic Networks","Global Change","Invasive Species","Climate Change",8,{"id":346,"displayName":347},"https:\u002F\u002Fopenalex.org\u002Fsubfields\u002F1105","Ecology, Evolution, Behavior and Systematics",{"id":349,"displayName":350},"https:\u002F\u002Fopenalex.org\u002Ffields\u002F11","Agricultural and Biological Sciences",{"id":202,"displayName":203},{"id":353,"displayName":354,"keywords":355,"worksCount":344,"score":17,"subfield":366,"field":369,"domain":372},"https:\u002F\u002Fopenalex.org\u002FT10542","Vestibular and auditory disorders",[356,357,358,359,360,361,362,363,364,365],"Cerebellum","Neuroimaging","Vestibular","Cognition","Motor Control","Functional Connectivity","Dizziness","Vertigo","Sudden Hearing Loss","Neurological Disorders",{"id":367,"displayName":368},"https:\u002F\u002Fopenalex.org\u002Fsubfields\u002F2808","Neurology",{"id":370,"displayName":371},"https:\u002F\u002Fopenalex.org\u002Ffields\u002F28","Neuroscience",{"id":202,"displayName":203},{"id":374,"displayName":375,"keywords":376,"worksCount":109,"score":17,"subfield":386,"field":389,"domain":390},"https:\u002F\u002Fopenalex.org\u002FT10185","Lymphoma Diagnosis and Treatment",[377,378,379,265,380,381,382,383,384,385],"Lymphoma","Classification","Molecular Profiling","Genetic Pathogenesis","PET Imaging","Hodgkin's Lymphoma","B-Cell Receptor Signaling","Mantle Cell Lymphoma","Gene Expression Profiling",{"id":387,"displayName":388},"https:\u002F\u002Fopenalex.org\u002Fsubfields\u002F2734","Pathology and Forensic Medicine",{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":392,"displayName":393,"keywords":394,"worksCount":90,"score":402,"subfield":403,"field":404,"domain":405},"https:\u002F\u002Fopenalex.org\u002FT10696","Gastric Cancer Management and Outcomes",[395,173,396,397,398,399,193,400,401,192],"Gastric Cancer","Endoscopic Resection","Molecular Characterization","Lymph Node Dissection","Adjuvant Therapy","Neoadjuvant Chemotherapy","Metastatic Gastric Cancer",0.9999,{"id":237,"displayName":238},{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":407,"displayName":408,"keywords":409,"worksCount":324,"score":402,"subfield":420,"field":423,"domain":424},"https:\u002F\u002Fopenalex.org\u002FT10771","Wound Healing and Treatments",[410,411,412,413,414,415,416,417,418,419],"Wound Healing","Regeneration","Macrophages","Fibroblasts","Chronic Wounds","Growth Factors","Hydrogel Dressings","Angiogenesis","Diabetes","Inflammation",{"id":421,"displayName":422},"https:\u002F\u002Fopenalex.org\u002Fsubfields\u002F2742","Rehabilitation",{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":426,"displayName":427,"keywords":428,"worksCount":344,"score":402,"subfield":437,"field":440,"domain":441},"https:\u002F\u002Fopenalex.org\u002FT11453","Diagnosis and Treatment of Venous Diseases",[429,430,431,432,433,193,434,152,435,436],"Chronic Venous Insufficiency","Varicose Veins","Venous Ulcers","Endovenous Treatment","Compression Therapy","Sclerotherapy","Epidemiology","Health Economic Burden",{"id":438,"displayName":439},"https:\u002F\u002Fopenalex.org\u002Fsubfields\u002F2746","Surgery",{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":443,"displayName":444,"keywords":445,"worksCount":324,"score":454,"subfield":455,"field":456,"domain":457},"https:\u002F\u002Fopenalex.org\u002FT12379","Cancer Diagnosis and Treatment",[446,447,448,379,449,450,451,385,452,453],"Cancer of Unknown Primary","Metastasis","Tissue of Origin","Immunohistochemistry","Diagnostic Algorithm","Soft Tissue Metastases","Unknown Primary Tumours","Clinical Management",0.9998,{"id":155,"displayName":156},{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":459,"displayName":460,"keywords":461,"worksCount":344,"score":454,"subfield":471,"field":474,"domain":475},"https:\u002F\u002Fopenalex.org\u002FT11395","Radiopharmaceutical Chemistry and Applications",[462,381,463,464,465,466,467,468,469,470],"Radiopharmaceuticals","Targeted Therapy","Radioimmunotherapy","Alpha Particle Therapy","Chelators","Nuclear Medicine","Bifunctional Agents","Dosimetry","Cancer Treatment",{"id":472,"displayName":473},"https:\u002F\u002Fopenalex.org\u002Fsubfields\u002F2741","Radiology, Nuclear Medicine and Imaging",{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":477,"displayName":478,"keywords":479,"worksCount":344,"score":454,"subfield":489,"field":490,"domain":491},"https:\u002F\u002Fopenalex.org\u002FT11369","Genetic factors in colorectal cancer",[397,480,481,482,483,484,485,486,487,488],"Microsatellite Instability","Hereditary Syndromes","DNA Mismatch Repair","Genetic Testing","Lynch Syndrome","Adjuvant Chemotherapy","Tumor Microsatellite-Instability","Polyposis Syndromes","Cancer Risk",{"id":387,"displayName":388},{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":493,"displayName":494,"keywords":495,"worksCount":109,"score":454,"subfield":505,"field":508,"domain":509},"https:\u002F\u002Fopenalex.org\u002FT10041","COVID-19 Clinical Research Studies",[496,497,435,498,499,500,501,502,503,504],"Clinical Characteristics","SARS-CoV-2","Thrombosis","Immune Response","ACE2 Receptor","Cytokine Storm","Antiviral Treatment","Pathophysiology","Pandemic",{"id":506,"displayName":507},"https:\u002F\u002Fopenalex.org\u002Fsubfields\u002F2725","Infectious Diseases",{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":511,"displayName":512,"keywords":513,"worksCount":521,"score":522,"subfield":523,"field":524,"domain":525},"https:\u002F\u002Fopenalex.org\u002FT10417","Lung Cancer Treatments and Mutations",[514,463,515,516,304,299,517,518,519,520],"EGFR Mutations","ALK Inhibitors","Resistance Mechanisms","Chemotherapy Regimens","Biomarker Analysis","Treatment Guidelines","Oncogene Addiction",17,0.9996,{"id":237,"displayName":238},{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":527,"displayName":528,"keywords":529,"worksCount":109,"score":536,"subfield":537,"field":540,"domain":541},"https:\u002F\u002Fopenalex.org\u002FT10073","Hepatocellular Carcinoma Treatment and Prognosis",[530,531,532,323,322,533,534,193,535,288],"Hepatocellular Carcinoma","Liver Cancer","Management","Radiofrequency Ablation","Sorafenib","Liver Resection",0.9993,{"id":538,"displayName":539},"https:\u002F\u002Fopenalex.org\u002Fsubfields\u002F2721","Hepatology",{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":543,"displayName":544,"keywords":545,"worksCount":324,"score":556,"subfield":557,"field":558,"domain":559},"https:\u002F\u002Fopenalex.org\u002FT11016","Monoclonal and Polyclonal Antibodies Research",[546,547,548,549,550,551,552,553,554,555],"Therapeutic Antibodies","Fc Receptors","Monoclonal Antibodies","Antibody Engineering","Immunoglobulin G","Nanobodies","Antibody Pharmacokinetics","Bispecific Antibodies","Glycosylation","Fc? Receptors",0.999,{"id":472,"displayName":473},{"id":158,"displayName":159},{"id":161,"displayName":162},{"id":561,"displayName":562,"keywords":563,"worksCount":289,"score":573,"subfield":574,"field":577,"domain":580},"https:\u002F\u002Fopenalex.org\u002FT10804","Health Systems, Economic Evaluations, Quality of Life",[564,152,565,566,567,568,569,570,571,572],"Cost-effectiveness Analysis","Health Utility Measures","EQ-5D","SF-36","QALY","Health Technology Assessment","Preference-based Measures","Economic Evaluation","Utility Index Scores",0.9988,{"id":575,"displayName":576},"https:\u002F\u002Fopenalex.org\u002Fsubfields\u002F2002","Economics and Econometrics",{"id":578,"displayName":579},"https:\u002F\u002Fopenalex.org\u002Ffields\u002F20","Economics, Econometrics and Finance",{"id":581,"displayName":582},"https:\u002F\u002Fopenalex.org\u002Fdomains\u002F2","Social Sciences",{"id":584,"displayName":585,"keywords":586,"worksCount":344,"score":594,"subfield":595,"field":596,"domain":597},"https:\u002F\u002Fopenalex.org\u002FT12505","Peptidase Inhibition and Analysis",[587,247,588,589,590,591,417,381,592,593],"Fibroblast Activation Protein","Immunosuppression","Cancer Therapy","N-terminal Acetylation","Protease Inhibitors","Stromal Cells","Tumor Stroma",0.9985,{"id":155,"displayName":156},{"id":158,"displayName":159},{"id":161,"displayName":162},1786496573861]